The most recent research released in June’s Journal of Thoracic Oncology indicates there might be a positive correlation between tumor size and adjuvant platinum based chemotherapy in surgically resected patients with node negative non-small cell lung cancer…

More:
Tumor Size May Predict Chemotherapy’s Effect On Overall Survival In Non-Small Cell Lung Cancer

The most recent research released in June’s Journal of Thoracic Oncology says molecular biomarkers in the tissue and fluid lining the lungs might be an additional predictive technique for lung cancer screening. Since the National Lung Screening Trial found that 96…

Read More:
Possible Diagnostic Technique For Lung Cancer Screening

The most recent research released in June’s Journal of Thoracic Oncology says video assisted thoracic surgery (VATS) is a valuable tool in managing lesions detected in a lung cancer screening program…

Read this article:
Valuable Tool In Lung Cancer Screening – Video-Assisted Thoracic Surgery

Cancer therapies targeting specific molecular subtypes of the disease allow physicians to tailor treatment to a patient’s individual molecular profile. But scientists are finding that in many types of cancer the molecular subtypes are more varied than previously thought and contain further genetic alterations that can affect a patient’s response to therapy…

Read More:
Response To Lung Cancer Therapy May Be Determined By Molecular Subtypes And Genetic Alterations

Researchers from the Spanish National Cancer Research Centre (CNIO), led by Jorge L. Martínez-Torrecuadrada from the Proteomics Unit, have demonstrated that the antibody-based blocking of ephrinB2, a protein involved in angiogenesis and lymphoangiogenesis, may represent an effective strategy for the development of antiangiogenic and antitumoural therapies…

Link:
Researchers Describe A New Target For Developing Anti-Angiogenic And Anti-Tumoral Therapies